Key facts
- This page summarizes Jess Roper's Form 4 filing for BIOLASE, INC (BIOLQ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 May 2022, 13:45.
Jess Roper - 28 Apr 2022 Form 4 Insider Report for BIOLASE, INC (BIOLQ)
- Reporting relationship
- Director
- Issuer ticker
- BIOLQ
- Reported as of
- 28 Apr 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 May 2022, 13:45:57 UTC
- Prior SEC filing
- 20 Jan 2022
- Next SEC filing
- 13 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael C. Carroll, attorney-in-fact for Jess Roper
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jess Roper filed Form 4 for BIOLASE, INC (BIOLQ) on 02 May 2022.
Change
- Previous filing in this sequence was filed on 20 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIOL
transaction
Series G Preferred Stock
Disposed to Issuer
- Transaction value
- Shares
- -346
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Apr 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On March 1, 2022, the Company's board of directors (the "Board") declared a dividend of one one-thousandth of a share of Series G Preferred Stock, par value $0.001 per share ("Preferred Stock"), for each outstanding share of Company Common Stock to stockholders of record at 5:00 p.m. Eastern Time on March 25, 2022 (the "Record Date"), in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on March 25, 2022. As a result, the Reporting Person received 345.863 shares of Preferred Stock. The Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company.
Footnote F2
On April 28, 2022, these shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation for the shares of Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.01 in cash for each ten whole shares of Preferred Stock, with any remaining shares (of less than 10) receiving no cash.